3541 - 3550 of 5832 Results
Title
Year
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
OPENTitle: Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 577Issue #: 7788Start Page: 103End Page: 108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-019-1828-5Best OA location URL: https://europepmc.org/articles/pmc6930849?pdf=renderCitation Count: 240
-
OPENTitle: PINK1 phosphorylates ubiquitin predominantly in astrocytesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0101-9Best OA location URL: https://www.nature.com/articles/s41531-019-0101-9.pdfCitation Count: 33
-
OPENTitle: Sex Differences in Cognitive Changes in De Novo Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 26Issue #: 2Start Page: 241End Page: 249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617719001085Best OA location URL: https://europepmc.org/articles/pmc7282562?pdf=renderCitation Count: 10
-
OPENTitle: Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next StepsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 19End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191854Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191854?id=journal-of-parkinsons-disease%2Fjpd191854Citation Count: 28
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 145
-
OPENTitle: Cerebellar Deep Brain Stimulation for Acquired HemidystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12876Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12876Citation Count: 50
- Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration2019OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://europepmc.org/articles/pmc7212500?pdf=renderCitation Count: 86
- Differences in topological progression profile among neurodegenerative diseases from imaging data2019OPENTitle: Differences in topological progression profile among neurodegenerative diseases from imaging dataJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.49298Best OA location URL: https://doi.org/10.7554/elife.49298Citation Count: 14
-
OPENTitle: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699Best OA location URL: https://europepmc.org/articles/pmc7011691?pdf=renderCitation Count: 30